BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Enoxacin

A broad-spectrum 6-fluoronaphthyridinone antibacterial agent that is structurally related to NALIDIXIC ACID.

299+ PubMed studies analyzed · 29 RCTs · Evidence Score: 45.3

Research Domains

Enoxacin has been studied across 15 research domains including 🧠 Focus & Attention, 🔬 Oncology, 🫘 Kidney, 🫁 Respiratory, 🦠 Gut & Microbiome. The primary research focus is 🧠 Focus & Attention with 9% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Enoxacin, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Galactitol
2 shared targets
Carbutamide
2 shared targets
Pyrrolidonecarboxylic
2 shared targets
Carduus
2 shared targets
Buthionine
2 shared targets
Pyridoxine
2 shared targets
Fomepizole
2 shared targets
pipemidic
2 shared targets
sulfameter
2 shared targets
Fluvastatin
2 shared targets
Loading evidence profile...

This evidence profile for Enoxacin is generated deterministically from 299 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.